Ovarian steroids reduce apoptosis induced by trophic insufficiency in nerve growth factor-differentiated PC12 cells and axotomized rat facial motoneurons

Neuroscience

Volumn 118, Issue 3, 2003, Pages 741-754

  MacLusky, N J ^a   Chalmers Redman, R ^b   Kay, G ^b   Ju, W ^b   Nethrapalli, I S ^a   Tatton, W G ^b  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

17 estradiol; Antiestrogen; Antiprogestin; Neuroprotection; Phaeochromocytoma; Progesterone

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; ESTRADIOL; ESTROGEN RECEPTOR BETA; FULVESTRANT; GROWTH FACTOR; LIGAND; NERVE GROWTH FACTOR; ONAPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN INHIBITOR; RNA; STEROID; STEROID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ASSAY; CELL COUNT; CELL DIFFERENTIATION; CELL STRAIN; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; HORMONE ACTION; HORMONE DETERMINATION; HORMONE INHIBITION; MATURITY; MOTONEURON; NERVE FIBER TRANSECTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; TIME;

EID: 0242669963     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00940-5     Document Type: Article

References (91)

1. Ansari K.S., Yu P.H., Kruck T.P., Tatton W.G. Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl stereospecificity and independence from monoamine oxidase inhibition . J Neurosci. 13:1993;4042-4053.
2. Birks J, Flicker L (2000) Selegiline for Alzheimer's disease. Cochrane Database Syst Rev CD000442.
3. Bonnefont A.B., Munoz F.J., Inestrosa N.C. Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes. FEBS Lett. 441:1998;220-224.
4. Bottenstein J.E., Skaper S.D., Varon S.S., Sato G.H. Selective survival of neurons from chick embryo sensory ganglionic dissociates utilizing serum-free supplemented medium. Exp Cell Res. 125:1980;183-190.
5. Bower J.H., Maraganore D.M., McDonnell S.K., Rocca W.A. Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease. Mov Disord. 15:2000;819-825.
6. Bretsky P.M., Buckwalter J.G., Seeman T.E., Miller C.A., Poirier J., Schellenberg G.D., Finch C.E., Henderson V.W. Evidence for an interaction between apolipoprotein E genotype, gender and Alzheimer disease. Alzheimer Dis Assoc Disord. 13:1999;216-221.
7. Brown T.J., MacLusky N.J. Progesterone modulation of estrogen receptors in microdissected regions of the rat hypothalamus. Mol Cell Neurosci. 5:1994;283-290.
8. Burek M.J., Oppenheim R.W. Programmed cell death in the developing nervous system. Brain Pathol. 6:1996;427-446.
9. Calderon F.H., Bonnefont A., Munoz F.J., Fernandez V., Videla L.A., Inestrosa N.C. PC12 and neuro 2a cells have different susceptibilities to acetylcholinesterase-amyloid complexes, amyloid25-35 fragment, glutamate, and hydrogen peroxide. J Neurosci Res. 56:1999;620-631.
10. 3H] progesterone to the human progesterone receptor differences between individual and mixed isoforms . Endocrinology. 137:1996;2339-2346.
11. Carlile G.W., Chalmers-Redman R.M., Tatton N.A., Pong A., Borden K.E., Tatton W.G. Reduced apoptosis after nerve growth factor and serum withdrawal conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer . Mol Pharmacol. 57:2000;2-12.
12. Casper R.F., MacLusky N.J., Vanin C., Brown T.J. Rationale for estrogen with interrupted progestin as a new low-dose hormonal replacement therapy. J Soc Gynecologic Invest. 3:1996;225-234.
13. Chalmers-Redman R.M., Fraser A.D., Carlile G.W., Pong A., Tatton W.G. Glucose protection from MPP+-induced apoptosis depends on mitochondrial membrane potential and ATP synthase. Biochem Biophys Res Commun. 257:1999;440-447.
14. Clemm D.L., Sherman L., Boonyaratanakornkit V., Schrader W.T., Weigel N.L., Edwards D.P. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol Endocrinol. 14:2000;52-65.
15. de Bilbao F., Dubois-Dauphin M. Time course of axotomy-induced apoptotic cell death in facial motoneurons of neonatal wild type and bcl-2 transgenic mice. Neuroscience. 71:1996;1111-1119.
16. DeMayo F.J., Zhao B., Takamoto N., Tsai S.Y. Mechanisms of action of estrogen and progesterone. Ann NY Acad Sci. 955:2002;48-59.
17. D'Souza A., Hinduja I.N., Kodali S., Moudgil V.K., Puri C.P. Interaction of newly synthesized antiprogesterone ZK98299 with progesterone receptor from human myometrium. Mol Cell Biochem. 139:1994;83-90.
18. Dubal D., Zhu H., Yu J., Rau S., Shughrue P., Merchenthaler I., Kindy M.S., Wise P.M. Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA. 98:2001;1952-1957.
19. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia a potential role for estrogen receptors . J Neurosci. 19:1999;6385-6393.
20. Ferrari G., Yan C.Y., Greene L.A. N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells. J Neurosci. 15:1995;2857-2866.
21. Freeman M.E. The ovarian cycle of the rat. Knobil E., Neill J. The physiology of reproduction. 1988;1893-1928 Raven Press, New York.
22. Gao J., Mazella J., Tang M., Tseng L. Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 (insulin-like growth factor binding protein-1) in human endometrial stromal cells. Mol Endocrinol. 14:2000;1954-1961.
23. Ginsburg M., Greenstein B.D., MacLusky N.J., Morris I.D. An improved method for the study of high-affinity steroid binding oestradiol binding in brain and pituitary . Steroids. 23:1974;773-792.
24. Ginsburg M., MacLusky N.J., Morris I.D., Thomas P.J. The specificity of oestrogen receptors in brain, pituitary and uterus. Br J Pharmacol. 59:1977;397-402.
25. Gollapudi L., Oblinger M.M. Estrogen and NGF synergistically protect terminally differentiated, ERα-transfected PC12 cells from apoptosis. J Neurosci Res. 56:1999;471-481.
26. Goodman Y.D., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid Beta-peptide toxicity in hippocampal neurons. J Neurochem. 66:1996;1836-1844.
27. Green P.S., Simpkins J.W. Neuroprotective effects of estrogens potential mechanisms of action . Int J Dev Neurosci. 18:2000;347-358.
28. Green P.S., Bishop J., Simpkins J.W. 17α-estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci. 17:1997;511-515.
29. Green P.S., Gridley K.E., Simpkins J.W. Nuclear estrogen receptor-independent neuroprotection by estratrienes a novel interaction with glutathione . Neuroscience. 84:1998;7-10.
30. Han B.H., Holtzman D.M. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci. 20:2000;5775-5781.
31. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond). 348:1990;334-336.
32. Hodgen G.D., Itskovitz J. Recognition and maintenance of pregnancy. Knobil E., Neill J. The physiology of reproduction. 1988;1995-2021 Raven Press, New York.
33. Honda K., Sawada H., Kihara T., Urushitani M., Nakamizo T., Akaike A., Shimohama S. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J Neurosci Res. 60:2000;321-327.
34. Houle J.D., Ye J.H. Survival of chronically-injured neurons can be prolonged by treatment with neurotrophic factors. Neuroscience. 94:1999;929-936.
35. Hoover D.B., Hancock J.C. Effect of facial nerve transection acetylcholinesterase, choline acetyltransferase and tritium quinuclidinyl benzylate binding in rat facial nucleus. Neuroscience. 15:1985;481-488.
36. Jorm A.F., Jolley D. The incidence of dementia a meta-analysis . Neurology. 51:1998;728-733.
37. Ju W.Y., Holland D.P., Tatton W.G. (-)-Deprenyl alters the time course of death of axotomized facial motoneurons and the hypertrophy of neighboring astrocytes in immature rats. Exp Neurol. 126:1994;233-246.
38. Jung-Testas I., Do Thi A., Koenig H., Desarnaud F., Shazand K., Schumacher M., Baulieu E.E. Progesterone as a neurosteroid synthesis and actions in rat glial cells . J Steroid Biochem Mol Biol. 69:1999;97-107.
39. Kato J., Hirata S., Nozawa A., Yamada-Mouri N. Gene expression of progesterone receptor isoforms in the rat brain. Horm Behav. 28:1994;454-463.
40. Knobil E., Hotchkiss J. The menstrual cycle and its neuroendocrine control. Knobil E., Neill J. The physiology of reproduction. 1988;1971-1994 Raven Press, New York.
41. Larsen J.P., Boas J., Erdal J.E. Does selegiline modify the progression of early Parkinson's disease? Results from a five-year study The Norwegian-Danish Study Group . Eur J Neurol. 6:1999;539-547.
42. Leonhardt S.A., Altmann M., Edwards D.P. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay. Mol Endocrinol. 12:1998;1914-1930.
43. Lustig R.H. Sex hormone modulation of neural development in vitro. Horm Behav. 28:1994;383-395.
44. MacLusky N.J., McEwen B.S. Progesterone receptors in rat brain distribution and properties of cytoplasmic progestin binding sites . Endocrinology. 106:1980;192-202.
45. Marder K., Tang M.X., Alfaro B., Mejia H., Cote L., Jacobs D., Stern Y., Sano M., Mayeux R. Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology. 50:1998;1141-1143.
46. Mattson M.P., Robinson N., Guo Q. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. Neuroreport. 8:1997;3817-3821.
47. McEwen B.S., Gould E., Orchinik M., Weiland N.G., Woolley C.S. Oestrogens and the structural and functional plasticity of neurons implications for memory, ageing and neurodegenerative processes . Ciba Found Symp. 191:1995;52-66.
48. Moosmann B., Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci USA. 96:1999;8867-8872.
49. Mulac-Jericevic B., Mullinax R.A., DeMayo F.J., Lydon J.P., Conneely O.M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science. 289:2000;1751-1754.
50. Nedvidkova J., Schreiber V., Starka L. In vivo antiestrogenic activity of mifepristone in the rat. J Endocrinol Invest. 20:1997;225-229.
51. Nilsen J., Brinton R.D. Impact of progestins on estrogen-induced neuroprotection synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate . Endocrinology. 143:2002;205-212.
52. Nilsen J., Mor G., Naftolin F. Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells. Menopause. 5:1998;211-216.
53. Nilsen J., Mor G., Naftolin F. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. J Neurobiol. 43:2000;64-78.
54. Oppenheim R.W. The absence of significant postnatal motoneuron death in the brachial and lumbar cord of the rat. J Comp Neurol. 246:1986;281-286.
55. Okulicz W.C., Evans R.W., Leavitt W.W. Progesterone regulation of the occupied form of nuclear estrogen receptor. Science. 213:1981;1503-1505.
56. Oyesiku N.M., Evans C.O., Houston S., Darrell R.S., Smith J.S., Fulop Z.L., Dixon C.E., Stein D.G. Regional changes in the expression of neurotrophic factors and their receptors following acute traumatic brain injury in the adult rat brain. Brain Res. 833:1999;161-172.
57. Pakkenberg B., Gundersen H.J. Solutions to old problems in the quantitation of the central nervous system. J Neurol Sci. 129:(suppl):1995;65-67.
58. Parsons B., Rainbow T.C., Snyder L., McEwen B.S. Progesterone-like effects of estradiol on reproductive behavior and hypothalamic progestin receptors in the female rat. Neuroendocrinology. 39:1984;25-30.
59. Petersen D.N., Tkalcevic G.T., Koza-Taylor P.H., Turi T.G., Brown T.A. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. Endocrinology. 139:1998;1082-1092.
60. Pike C.J. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis relevance to Alzheimer's disease . J Neurochem. 72:1999;1552-1563.
61. Price R.H. Jr, Butler C.A., Webb P., Uht R., Kushner P., Handa R.J. A splice variant of estrogen receptor beta missing exon 3 displays altered subnuclear localization and capacity for transcriptional activation. Endocrinology. 142:2001;2039-2049.
62. Price R.H. Jr, Lorenzon N., Handa R.J. Differential expression of estrogen receptor beta splice variants in rat brain identification and characterization of a novel variant missing exon 4 . Brain Res Mol Brain Res. 80:2000;260-268.
63. Roof R.L., Hall E.D. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma. 17:2000;367-388.
64. Salo P.T., Tatton W.G. Deprenyl reduces the death of motoneurons caused by axotomy. J Neurosci Res. 31:1992;394-400.
65. Saunders-Pullman R., Gordon-Elliott J., Parides M., Fahn S., Saunders H.R., Bressman S. The effect of estrogen replacement on early Parkinson's disease. Neurology. 52:1999;1417-1421.
66. Sawada H., Ibi M., Kihara T., Urushitani M., Akaike A., Shimohama S. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J Neurosci Res. 54:1998;707-719.
67. Schmidt R., Fazekas F., Reinhart B., Kapeller P., Fazekas G., Offenbacher H., Eber B., Schumacher M., Freidl W. Estrogen replacement therapy in older women a neuropsychological and brain MRI study . J Am Geriatr Soc. 44:1996;1307-1313.
68. Siegel S (1956) Non-parametric statistics for the behavioral sciences. New York: McGraw-Hill.
69. Sherwin B.B. Estrogen effects on cognition in menopausal women. Neurology. 48:1997;S21-26.
70. Simpkins J.W., Rajakumar G., Zhang Y.Q., Simpkins C.E., Greenwald D., Yu C.J., Bodor N., Day A.L. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg. 87:1997;724-730.
71. Singh M., Setalo G. Jr, Guan X., Frail D.E., Toran-Allerand C.D. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice. J Neurosci. 20:2000;1694-1700.
72. Sohrabji F., Greene L.A., Miranda R.C., Toran-Allerand C.D. Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. J Neurobiol. 25:1994;974-988.
73. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
74. Tanzer L., Sengelaub D.R., Jones K.J. Estrogen receptor expression in the facial nucleus of adult hamsters does axotomy recapitulate development? J Neurobiol. 39:1999;438-446.
75. Tatton W.G., Ju W.Y., Holland D.P., Tai C., Kwan M. (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J Neurochem. 63:1994;1572-1575.
76. Tatton W.G., Chalmers-Redman R.M.E., Ju J.H., Holland D.P., Mammen M., Carlile A.W., Pong A.W., Tatton N.A. Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC12 cells. J Pharmacol Exp Ther. 301:2002;753-764.
77. Toran-Allerand C.D., Singh M., Setalo G. Jr. Novel mechanisms of estrogen action in the brain new players in an old story . Front Neuroendocrinol. 20:1999;97-121.
78. Tsutsui K., Ukena K., Takase M., Kohchi C., Lea R.W. Neurosteroid biosynthesis in vertebrate brains. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 124:1999;121-129.
79. Veliskova J., Velisek L., Galanopoulou A.S., Sperber E.F. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia. 41:(suppl 6):2000;S30-S35.
80. Wade C.B., Robinson S., Shapiro R.A., Dorsa D.M. Estrogen receptor (ER) alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology. 142:2001;2336-2342.
81. Wadia J.S., Chalmers-Redman R.M.E., Ju W.J.H., Carlile G.W., Phillips J.L., Fraser A.D., Tatton W.G. Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal time course and modification by (-)-deprenyl . J Neurosci. 18:1998;932-947.
82. Wakeling A.E. Use of pure antioestrogens to elucidate the mode of action of oestrogens. Biochem Pharmacol. 49:1995;1545-1549.
83. West M.J., Slomianka L., Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec. 231:1991;482-497.
84. Williams R.W., Rakic P. Three-dimensional counting an accurate and direct method to estimate numbers of cells in sectioned material . J Comp Neurol. 278:1988;344-352.
85. Wilson M.E., Dubal D.B., Wise P.M. Estradiol protects against injury-induced cell death in cortical explant cultures a role for estrogen receptors . Brain Res. 873:2000;235-242.
86. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Liu Y. Estrogens trophic and protective factors in the adult brain . Front Neuroendocrinol. 22:2001;33-66.
87. Yaffe K., Sawaya G., Lieberburg I., Grady D. Estrogen therapy in postmenopausal women effects on cognitive function and dementia . JAMA. 279:1998;688-695.
88. Yokosuka M., Hayashi S. Transient expression of estrogen-receptor-like immunoreactivity (ER-LI) in the facial nucleus of the neonatal rat. Neurosci Res. 15:1992;90-95.
89. Yu W.H. Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment. Brain Res. 491:1989;379-382.
90. Zhang F., Richardson P.M., Holland D.P., Guo Q., Tatton W.G. CNTF or (-)-deprenyl in immature rats survival of axotomized facial motoneurons and weight loss . J Neurosci Res. 40:1995;564-570.
91. Zhang Y.Q., Shi J., Rajakumar G., Day A.L., Simpkins J.W. Effects of gender and estradiol treatment on focal brain ischemia. Brain Res. 784:1998;321-324.